Safety of adjunctive perampanel by titration/maintenance periods and dose in patients with focal-onset seizures: Post hoc analysis of the FAME study

被引:0
|
作者
Kim, Dong Wook [1 ]
Kim, Ji Hyun [2 ]
Dash, Amitabh [3 ]
Lee, JiWoong [4 ]
Malhotra, Manoj [5 ]
机构
[1] Konkuk Univ, Sch Med, Seoul, South Korea
[2] Korea Univ, Guro Hosp, Seoul, South Korea
[3] Eisai Singapore Pte Ltd, Singapore, Singapore
[4] Eisai Korea Inc, Seoul, South Korea
[5] Eisai Inc, Woodcliff Lake, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
128
引用
收藏
页码:43 / 44
页数:2
相关论文
共 50 条
  • [21] Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures:A real-world experience in eastern China
    Xu, Sha
    Xu, Zheng-yan-ran
    Zheng, Yuanyuan
    Miao, Pu
    Feng, Jianhua
    Guo, Yi
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 110 : 231 - 237
  • [22] Long-Term Efficacy and Safety of Adjunctive Perampanel in Elderly Patients with Focal-Onset Seizures by Concomitant Anti-Seizure Medication (ASM) Use
    Marawar, Rohit
    Leppik, Ilo E.
    Wechsler, Robert T.
    Patten, Anna
    Ngo, Leock Y.
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 53 - 54
  • [23] EFFECT OF LOW DOSE ADJUNCTIVE PERAMPANEL IN ADULTS AND ADOLESCENTS WITH FOCAL- ONSET SEIZURES
    Giallonardo, Anna Teresa
    Aguglia, Umberto
    Goldman, Samantha
    Chiacchiaretta, Martina
    Gentile, Anna
    Patten, Anna
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [24] Efficacy and Safety of Perampanel in Children with Drug-Resistant Focal-Onset Seizures: A Retrospective Review
    Elmardenly, Ahmed
    Aljehani, Zekra
    Tamim, Abdullah
    Alyazidi, Anas
    Muthaffar, Osama
    CHILDREN-BASEL, 2023, 10 (06):
  • [25] Effectiveness and safety of perampanel as adjunctive therapy among Chinese patients with focal-onset epilepsy: A real-world prospective observational study
    Wang, Qinyue
    Xu, Ye
    Chen, Yuncan
    Wu, Xunyi
    Ge, Yan
    Zhu, Guoxing
    EPILEPSY & BEHAVIOR, 2022, 136
  • [26] Adjunctive perampanel 4 mg/day for focal-onset seizures (FOS): Time to seizure onset in pivotal phase III studies
    Salah, Alejandro
    Patten, Anna
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 42 - 43
  • [27] Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
    Jin, Yang
    Zhang, Ranran
    Jiang, Jing
    Liu, Xuewu
    ACTA NEUROLOGICA BELGICA, 2023, 123 (03) : 1081 - 1087
  • [28] Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
    Yang Jin
    Ranran Zhang
    Jing Jiang
    Xuewu Liu
    Acta Neurologica Belgica, 2023, 123 : 1081 - 1087
  • [29] Efficacy and safety of adjunctive perampanel 4 mg/day in patients aged 4-<12 years with focal-onset seizures or generalised tonic-clonic seizures
    Moretz, Katherine
    Malhotra, Manoj
    Patten, Anna
    Ngo, Leock Y.
    EPILEPSIA, 2021, 62 : 269 - 269
  • [30] Cenobamate as early adjunctive treatment in refractory focal-onset seizures: a cohort study
    Winter, Y.
    Civelek, A.
    Sandner, K.
    Apel, D.
    Abou Dargham, R.
    Tobon, S. P.
    Groppa, S.
    EPILEPSIA, 2023, 64 : 315 - 316